Financial Partners Capital Management’s Celgene Corp CELG Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2018
Q3
Sell
-28,589
Closed -$2.27M 83
2018
Q2
$2.27M Sell
28,589
-456
-2% -$37.9K 0.69% 40
2018
Q1
$2.59M Buy
29,045
+1,900
+7% +$182K 0.78% 40
2017
Q4
$2.83M Buy
27,145
+45
+0.2% +$5.08K 0.52% 57
2017
Q3
$3.95M Sell
27,100
-425
-2% -$57.9K 0.76% 51
2017
Q2
$3.58M Sell
27,525
-200
-0.7% -$24.5K 0.75% 50
2017
Q1
$3.45M Sell
27,725
-395
-1% -$47.3K 0.76% 50
2016
Q4
$3.25M Sell
28,120
-150
-0.5% -$16.7K 0.78% 48
2016
Q3
$2.83M Buy
28,270
+1,085
+4% +$117K 0.72% 49
2016
Q2
$2.68M Buy
+27,185
New +$2.81M 0.72% 47

Other funds holding CELG

Financial Partners Capital Management's CELG Position: Q3 2018 in Review

Financial Partners Capital Management sold out of Celgene Corp (CELG) in Q3 2018, closing a stake of 28,589 shares — an estimated $2.27M sold.

Financial Partners Capital Management first reported a position in CELG in Q2 2016 and held it in 9 quarters. The position peaked at $3.95M in Q3 2017. 1,364 funds tracked by Wall St. Rank hold CELG as of Q3 2018.

  • Financial Partners Capital Management reported no remaining Celgene Corp position as of Q3 2018 after selling out during the quarter.
  • Financial Partners Capital Management sold 28,589 Celgene Corp shares in Q3 2018, an estimated $2.27M.
  • Financial Partners Capital Management first reported a position in Celgene Corp in Q2 2016 and held it in 9 quarters.
  • Financial Partners Capital Management's Celgene Corp position peaked at $3.95M in Q3 2017.
  • 1,364 funds tracked by Wall St. Rank held Celgene Corp as of Q3 2018.

Based on Financial Partners Capital Management's 13F filing for Q3 2018, filed 19 Feb 2019.